Utilization of human DC-SIGN and L-SIGN for entry and infection of host cells by the New World arenavirus, Junín virus

Biochemical and Biophysical Research Communications

Volumn 441, Issue 3, 2013, Pages 612-617

  Martinez, M G ^a,b,c   Bialecki, Michele A ^a   Belouzard, Sandrine ^a,d   Cordo, Sandra M ^b   Candurra, Nélida A ^b   Whittaker, Gary R ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Jun n arenavirus; Lectin; Virus entry; Virus receptor

Indexed keywords

CD209 ANTIGEN; LECTIN; MEMBRANE PROTEIN; PROTEIN L SIGN; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; HOST CELL; HUMAN; INTERNALIZATION; JUNIN VIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS CULTURE; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS PARTICLE;

ARENAVIRUS; JUNIN VIRUS;

JUNÍN ARENAVIRUS; LECTIN; VIRUS ENTRY; VIRUS RECEPTOR;

3T3 CELLS; ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; CERCOPITHECUS AETHIOPS; HEMORRHAGIC FEVER, AMERICAN; HOST-PATHOGEN INTERACTIONS; HUMANS; JUNIN VIRUS; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFERRIN; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84888296984     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.106     Document Type: Article

References (34)

1. Buchmeier M.J., de la Torre J.-C., Peters C.J. Arenaviridae. Fields Virology 2013, 1283-1303. Lippincott Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
2. Grant A., Seregin A., Huang C., Kolokoltsova O., Brasier A., Peters C., Paessler S. Junin virus pathogenesis and virus replication. Viruses 2012, 4:2317-2339.
3. Nunberg J.H., York J. The curious case of arenavirus entry, and its inhibition. Viruses 2012, 4:83-101.
4. Rojek J.M., Kunz S. Cell entry by human pathogenic arenaviruses. Cell. Microbiol. 2008, 10:828-835.
5. Cao W., Henry M.D., Borrow P., Yamada H., Elder J.H., Ravkov E.V., Nichol S.T., Compans R.W., Campbell K.P., Oldstone M.B. Identification of alpha dystroglycan as a receptor for lymphocytic choriomeningitis virus and lassa fever virus. Science 1998, 282:2079-2081.
6. Spiropoulou C.F., Kunz S., Rollin P.E., Campbell K.P., Oldstone M.B.A. New World Arenavirus clade C, but not clade A and B viruses, utilizes {alpha}-dystroglycan as its major receptor. J. Virol. 2002, 76:5140-5146.
7. Abraham J., Kwong J.A., Albarino C.G., Lu J.G., Radoshitzky S.R., Salazar-Bravo J., Farzan M., Spiropoulou C.F., Choe H. Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog. 2009, 5:e1000358.
8. Radoshitzky S.R., Kuhn J.H., Spiropoulou C.F., AlbariAo C.s.G., Nguyen D.P., Salazar-Bravo J., Dorfman T., Lee A.S., Wang E., Ross S.R., Choe H., Farzan M. Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. Proc. Nat. Acad. Sci. 2008, 105:2664-2669.
9. Radoshitzky S.R., Abraham J., Spiropoulou C.F., Kuhn J.H., Nguyen D., Li W., Nagel J., Schmidt P.J., Nunberg J.H., Andrews N.C., Farzan M., Choe H. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 2007, 446:92-96.
10. Cuevas C.D., Lavanya M., Wang E., Ross S.R. Junin virus infects mouse cells and induces innate immune responses. J. Virol. 2011, 85:11058-11068.
11. Flanagan M.L., Oldenburg J., Reignier T., Holt N., Hamilton G.A., Martin V.K., Cannon P.M. New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J. Virol. 2008, 82:938-948.
12. Geijtenbeek T.B.H., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C.F., Middel J., Cornelissen I.L.M.H.A., Nottet H.S.L.M., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
13. Baribaud F., Pohlmann S., Leslie G., Mortari F., Doms R.W. Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J. Virol. 2002, 76:9135-9142.
14. Cambi A., Koopman M., Figdor C.G. How C-type lectins detect pathogens. Cell. Microbiol. 2005, 7:481-488.
15. Lozach P.-Y., Burleigh L., Staropoli I., Amara A. The C type lectins DC-SIGN and L-SIGN. Methods Mol. Biol. 2007, 51-68.
16. Shimojima M., Kawaoka Y. Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein. J. Vet. Med. Sci. 2012, 74:1363-1366.
17. Shimojima M., Stroher U., Ebihara H., Feldmann H., Kawaoka Y. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. J. Virol. 2012, 86:2067-2078.
18. Feinberg H., Mitchell D.A., Drickamer K., Weis W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 2001, 294:2163-2166.
19. Mitchell D.A., Fadden A.J., Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. J. Biol. Chem. 2001, 276:28939-28945.
20. Pohlmann S., Zhang J., Baribaud F., Chen Z., Leslie G.J., Lin G., Granelli-Piperno A., Doms R.W., Rice C.M., McKeating J.A. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 2003, 77:4070-4080.
21. Alvarez C.P., Lasala F., Carrillo J., Muniz O., Corbi A.L., Delgado R. C-Type lectins DC-SIGN and L-SIGN mediate cellular entry by ebola virus in cis and in trans. J. Virol. 2002, 76:6841-6844.
22. Han D.P., Lohani M., Cho M.W. Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J. Virol. 2007, 81:12029-12039.
23. Halary F., Amara A., Lortat-Jacob H., Messerle M., Delaunay T., Houlès C., Fieschi F., Arenzana-Seisdedos F., Moreau J.-F., Déchanet-Merville J. Human cytomegalovirus binding to dc-sign is required for dendritic cell infection and target cell trans-infection. Immunity 2002, 17:653-664.
24. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003, 197:823-829.
25. Grutadauria S., Castilla V., Zapata M., Mersich S. Analysis of viral glycoproteins by glycosidic digestion inside a polyacrylamide gel. J. Virol. Methods 1999, 80:217-221.
26. Martinez M.G., Prado Acosta M., Candurra N.A., Ruzal S.M. S-layer proteins of Lactobacillus acidophilus inhibits JUNV infection. Biochem. Biophys. Res. Commun. 2012, 422:590-595.
27. Contigiani M., Sabattini M. Virulencia diferencial de cepas de virus Junin por marcadores biológicos en ratones y cobayos. Medicinas (Buenos Aires) 1977, 37(Suppl. 3):244-251.
28. Bartosch B., Dubuisson J., Cosset F.-L. Infectious Hepatitis c virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 2003, 197:633-642.
29. Gardner J.P., Durso R.J., Arrigale R.R., Donovan G.P., Maddon P.J., Dragic T., Olson W.C. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Nat. Acad. Sci. USA 2003, 100:4498-4503.
30. Rappocciolo G., Hensler H.R., Jais M., Reinhart T.A., Pegu A., Jenkins F.J., Rinaldo C.R. Human herpesvirus 8 infects and replicates in primary cultures of activated b lymphocytes through DC-SIGN. J. Virol. 2008, 82:4793-4806.
31. Granelli-Piperno A., Pritsker A., Pack M., Shimeliovich I., Arrighi J.F., Park C.G., Trumpfheller C., Piguet V., Moran T.M., Steinman R.M. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 2005, 175:4265-4273.
32. Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F., Whitbeck J.C., Burke E., Buchmeier M.J., Soilleux E.J., Riley J.L., Doms R.W., Bates P., Pöhlmann S. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305:115-123.
33. Lin G., Simmons G., Pohlmann S., Baribaud F., Ni H., Leslie G.J., Haggarty B.S., Bates P., Weissman D., Hoxie J.A., Doms R.W. Differential N-linked glycosylation of human immunodeficiency virus and ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 2003, 77:1337-1346.
34. Colmenares M., Puig-Kroger A., Pello O.M., Corbi A.L., Rivas L. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem. 2002, 277:36766-36769.